News

Marilyn K. Glassberg, M.D., speaking at the Vatican.

Dr. Marilyn K. Glassberg Presents Research Findings at Vatican Stem Cell Conference

When Marilyn K. Glassberg, M.D., professor of medicine, surgery and pediatrics, spoke at an international conference held at the Vatican, she delivered a moving account of the promising early results obtained by investigators at the University of Miami Miller School of Medicine in a small clinical trial that explored stem cell treatment in patients with idiopathic pulmonary fibrosis (IPF).

Read more »

Marilyn K. Glassberg, M.D., speaking at the Vatican.

Dr. Marilyn K. Glassberg Presents Research Findings at Vatican Stem Cell Conference

When Marilyn K. Glassberg, M.D., professor of medicine, surgery and pediatrics, spoke at an international conference held at the Vatican, she delivered a moving account of the promising early results obtained by investigators at the University of Miami Miller School of Medicine in a small clinical trial that explored stem cell treatment in patients with idiopathic pulmonary fibrosis (IPF).

Read more »

Christine L. Curry, M.D., Ph.D., speaking to Miami Beach City Commissioners about the Zika virus threat.

Miller School Clinicians and Researchers Urge Proactive Approach to Controlling Zika Virus

Controlling the mosquito-borne Zika virus must continue to be a public health priority for South Florida, according to several University of Miami Miller School of Medicine clinicians and researchers who spoke on September 14 at a public hearing held by the Miami Beach City Commission.

Read more »

From left, John C. Beier, Sc.D., David Watkins, Ph.D., Mario Stevenson, Ph.D., President Julio Frenk, Christine L. Curry, M.D., Ph.D., Ivan A. Gonzalez, M.D., and Paola N. Lichtenberger, M.D.

Expert Panel Discusses Variety of Responses by UM to Zika Virus Challenge

At a Zika symposium hosted by the University of Miami, the Miller School of Medicine, and UHealth – the University of Miami Health System today, UM President Julio Frenk called on Congress to approve emergency federal funding for Zika research, treatment and monitoring.

Read more »

From left, Roland Jurecic, Ph.D., Paolo Serafini, Ph.D., Samita Andreansky, Ph.D., and Richard L. Riley, Ph.D.

Interdisciplinary Team Awarded $3.4 Million to Research Safer, Improved Chemotherapy

Armed with a new $3.4 million grant from the National Cancer Institute (NCI), an interdisciplinary research team of Sylvester Comprehensive Cancer Center members is creating a blueprint that may help to deliver safer, more-effective chemotherapy, with far fewer long-term negative health consequences.

Read more »